-
What do we need to know to improve the lives of older people, their families, and their communities? Through an interactive and engaging discussion, this online event highlighted the importance of knowledge sharing across sectors, disciplines, and regions to work together to foster healthy ageing across the globe. The event also launched the...
20 September 2021
-
Cochrane is preparing a series of reviews to help decision makers with their response to COVID-19. Each Cochrane podcast offers a short summary of a recent Cochrane COVID-19 review from the authors themselves. They allow everyone from healthcare professionals to patients and families to hear the latest Cochrane evidence in under five minutes.
...
20 September 2021
-
A recently published Cochrane review explores what measures can be taken in long-term care facilities to prevent COVID-19 outbreaks.
Can non-medicinal measures prevent or reduce SARS-CoV-2 infections in long term care facilities?
Key messages
Non-medicinal measures (e.g. visiting restrictions or regular testing) may prevent...
15 September 2021
-
In this author interview with Stephanie Weibel and Maria Popp, we find out more about their Cochrane review, Ivermectin for treating and preventing COVID-19. The review currently has an Altmetric Attention Score of more than 7000, which makes it the most talked-about review in the history of the Cochrane Library.
Briefly, what is...
14 September 2021
-
Cochrane Convenes will bring together key thought leaders from around the world to discuss the COVID-19 evidence response and develop recommendations to help prepare for and respond to future global health emergencies.
In this interview, we talk to John Lavis, a member of the Cochrane Convenes steering group, about what he hopes will come out of...
13 September 2021
-
Would you choose a treatment option that might increase your risk of developing dementia?
Anticholinergic drugs (which can relax smooth muscle, increase heart rate, and reduce bodily secretions) are commonly used in clinical practice for the management of many conditions affecting older adults - for example for urinary incontinence and for...
9 September 2021
-
We chatted with Jen Ma of Gentle Facts about how art can help in communicating science and health evidence, the challenges involved, and her work to address these.
Can you tell us a bit about yourself and background?
My name is Jennifer Ma (I go by Jen). I am a researcher by training and did my PhD in the Stem Cell Bioengineering lab at the...
9 September 2021
-
'SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19' from Cochrane Haematology published today in the Cochrane Library.
Key messages
We do not know whether antibodies (the body’s natural defence against disease) made in a laboratory and all the same as one another (monoclonal) and designed to target COVID-19, are an...
2 September 2021
-
Cochrane are signing a collaboration licence agreement with NICE, the National Institute for Health and Care Excellence, the UK government’s guideline organization. Cochrane has a long-established relationship with the NHS and the National Institute for Health research (NIHR), and Cochrane Reviews are already used to inform NICE guidelines. The...
1 September 2021
-
The Governing Board voted unanimously to re-appoint Catherine Marshall for a second term as Co-Chair from September 2021 until September 2023. Catherine will continue to work alongside fellow Co-Chair, Tracey Howe.
The Governing Board is responsible for setting Cochrane's strategic direction and overseeing the work of the Chief...
24 August 2021
-
24 August 2021
-
Cochrane Library Special Collections provide a round-up of up-to-date Cochrane evidence on a specific topic. This Special Collection has been created to highlight evidence-based interventions to reduce stillbirth and improve care for families after stillbirth and in a subsequent pregnancy, identify women at increased risk of stillbirth, and...
24 August 2021
-
Cochrane is delighted to launch a Russian translation of MECIR (Methodological Expectations for Cochrane Intervention Reviews) from Cochrane Russia.
This is the third translation of Cochrane’s methods guidance since the launch of version 6 of the Cochrane Handbook for Systematic Reviews of Interventions (see this Cochrane Editorial for more...
23 August 2021
-
16 August 2021
-
Are corticosteroids (anti-inflammatory medicines) given orally or by injection an effective treatment for people with COVID-19?
Key messages
Corticosteroids (anti-inflammatory medicines) given orally or by injection (systemic) are probably effective treatments for people hospitalised with COVID-19. The authors don’t know whether they cause...
16 August 2021
-
What can individuals do, especially those with long-term breathing problems, to avoid the effects of air pollution?
This recently published Cochrane review explores this question, and we sat down with the lead author of the review to discuss the review findings.
Tell us about this Cochrane review…What did you find out?
The main thing that we...
9 August 2021
-
In this recently published Cochrane review, authors explored the effects of treating COVID-19 with remdesivir, an antiviral medication.
First author Kelly Ansems said "Based on the currently available evidence remdesivir probably has little or no effect on all-cause mortality at up to 28 days in hospitalised adults with SARS-CoV-2 infection. We...
5 August 2021
-
Is ivermectin effective for COVID-19?
Key messages
The authors of this Cochrane systematic review, published today by Cochrane Infectious Diseases Group, found no evidence to support the use of ivermectin for treating or preventing COVID-19 infection, but the evidence base is limited.
Evaluation of ivermectin is continuing in 31 ongoing studies;...
28 July 2021
-
The Cochrane Methods team has defined a programme of work to improve the quality and impact of Cochrane reviews in public health with the support of the Methods Executive, Methods Groups and Public Health and Health Systems Network. The programme has been designed to foster collaboration between Methods Groups and Cochrane Review Group (CRG)...
27 July 2021
-
26 July 2021
What do we need to know to improve the lives of older people, their families, and their communities? Through an interactive and engaging discussion, this online event highlighted the importance of knowledge sharing across sectors, disciplines, and regions to work together to foster healthy ageing across the globe. The event also launched the...20 September 2021
Cochrane is preparing a series of reviews to help decision makers with their response to COVID-19. Each Cochrane podcast offers a short summary of a recent Cochrane COVID-19 review from the authors themselves. They allow everyone from healthcare professionals to patients and families to hear the latest Cochrane evidence in under five minutes. ...20 September 2021
A recently published Cochrane review explores what measures can be taken in long-term care facilities to prevent COVID-19 outbreaks.
In this author interview with Stephanie Weibel and Maria Popp, we find out more about their Cochrane review, Ivermectin for treating and preventing COVID-19. The review currently has an Altmetric Attention Score of more than 7000, which makes it the most talked-about review in the history of the Cochrane Library.
Cochrane Convenes will bring together key thought leaders from around the world to discuss the COVID-19 evidence response and develop recommendations to help prepare for and respond to future global health emergencies. In this interview, we talk to John Lavis, a member of the Cochrane Convenes steering group, about what he hopes will come out of...13 September 2021
Would you choose a treatment option that might increase your risk of developing dementia? Anticholinergic drugs (which can relax smooth muscle, increase heart rate, and reduce bodily secretions) are commonly used in clinical practice for the management of many conditions affecting older adults - for example for urinary incontinence and for...9 September 2021
We chatted with Jen Ma of Gentle Facts about how art can help in communicating science and health evidence, the challenges involved, and her work to address these. Can you tell us a bit about yourself and background?
'SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19' from Cochrane Haematology published today in the Cochrane Library. Key messages We do not know whether antibodies (the body’s natural defence against disease) made in a laboratory and all the same as one another (monoclonal) and designed to target COVID-19, are an...2 September 2021
Cochrane are signing a collaboration licence agreement with NICE, the National Institute for Health and Care Excellence, the UK government’s guideline organization. Cochrane has a long-established relationship with the NHS and the National Institute for Health research (NIHR), and Cochrane Reviews are already used to inform NICE guidelines. The...1 September 2021
The Governing Board voted unanimously to re-appoint Catherine Marshall for a second term as Co-Chair from September 2021 until September 2023. Catherine will continue to work alongside fellow Co-Chair, Tracey Howe.
24 August 2021
Cochrane Library Special Collections provide a round-up of up-to-date Cochrane evidence on a specific topic. This Special Collection has been created to highlight evidence-based interventions to reduce stillbirth and improve care for families after stillbirth and in a subsequent pregnancy, identify women at increased risk of stillbirth, and...24 August 2021
Cochrane is delighted to launch a Russian translation of MECIR (Methodological Expectations for Cochrane Intervention Reviews) from Cochrane Russia. This is the third translation of Cochrane’s methods guidance since the launch of version 6 of the Cochrane Handbook for Systematic Reviews of Interventions (see this Cochrane Editorial for more...23 August 2021
16 August 2021
Are corticosteroids (anti-inflammatory medicines) given orally or by injection an effective treatment for people with COVID-19? Key messages Corticosteroids (anti-inflammatory medicines) given orally or by injection (systemic) are probably effective treatments for people hospitalised with COVID-19. The authors don’t know whether they cause...16 August 2021
What can individuals do, especially those with long-term breathing problems, to avoid the effects of air pollution? This recently published Cochrane review explores this question, and we sat down with the lead author of the review to discuss the review findings. Tell us about this Cochrane review…What did you find out? The main thing that we...9 August 2021
In this recently published Cochrane review, authors explored the effects of treating COVID-19 with remdesivir, an antiviral medication. First author Kelly Ansems said "Based on the currently available evidence remdesivir probably has little or no effect on all-cause mortality at up to 28 days in hospitalised adults with SARS-CoV-2 infection. We...5 August 2021
Is ivermectin effective for COVID-19? Key messages The authors of this Cochrane systematic review, published today by Cochrane Infectious Diseases Group, found no evidence to support the use of ivermectin for treating or preventing COVID-19 infection, but the evidence base is limited. Evaluation of ivermectin is continuing in 31 ongoing studies;...28 July 2021
The Cochrane Methods team has defined a programme of work to improve the quality and impact of Cochrane reviews in public health with the support of the Methods Executive, Methods Groups and Public Health and Health Systems Network. The programme has been designed to foster collaboration between Methods Groups and Cochrane Review Group (CRG)...27 July 2021
26 July 2021